ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

Submit article

737-volumetric-arc-therapy-for-total-scalp-irradiation-case-report-for-a-recurrent-basal-cell-carcinoma-of-the-scalp

Case Report: Volumetric arc therapy for total scalp irradiation: case report for a recurrent basal cell carcinoma of the scalp

Francisco Lozano, Naipy Perez, Alejandro Iglesias, Xiaodong Xu, Marco A Amendola, Michael Scott, Erich Companioni, Beatriz E Amendola

11 May 2017

https://doi.org/10.3332/ecancer.2017.737

Abstract | Full Article | PDF

731-penile-melanoma-a-20-year-analysis-of-six-patients-at-the-national-cancer-institute-of-peru-lima

Case Report: Penile melanoma: a 20-Year analysis of six patients at the National Cancer Institute of Peru, Lima

Andres Guevara Jabiles, Edilberto Yabar Del Mar, Gilmer Arcenio Diaz Perez, Fernando Quiroa Vera, Luis Meza Montoya, Carlos Manuel Morante Deza

4 Apr 2017

https://doi.org/10.3332/ecancer.2017.731

Abstract | Full Article | PDF | Spanish

730-highlights-from-the-first-ecancer-liga-colombiana-contra-el-cancer-conference-17-18-november-2016-bogota-colombia

Conference Report: Highlights from the first ecancer–Liga Colombiana contra el Cancer conference, 17–18 November 2016, Bogota, Colombia

Carlos Castro

28 Mar 2017

https://doi.org/10.3332/ecancer.2017.730

Abstract | Full Article | PDF | Spanish

691-cancer-immunotherapy-from-the-lab-to-clinical-applications-potential-impact-on-cancer-centres-organisation

Conference Report: Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada

9 Nov 2016

https://doi.org/10.3332/ecancer.2016.691

Abstract | Full Article | PDF

690-postoperative-radiotherapy-in-the-management-of-keloids

Research: Postoperative radiotherapy in the management of keloids

Claudia C Carvajal, Carla M Ibarra, Douglas L Arbulo, Moisés N Russo, Claudio P Solé

8 Nov 2016

https://doi.org/10.3332/ecancer.2016.690

Abstract | Full Article | PDF | Spanish

677-veror-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions

Research: VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

R Orecchia, A Surgo, M Muto, A Ferrari, G Piperno, MA Gerardi, S Comi, C Garibaldi, D Ciardo, A Bazani, F Golino, F Pansini, C Fodor, P Romanelli, D Maestri, V Scroffi, S Mazza, BA Jereczek-Fossa

29 Sep 2016

https://doi.org/10.3332/ecancer.2016.677

Abstract | Full Article | PDF

624-dabrafenib-in-metastatic-melanoma-a-monocentric-real-life-experience

Clinical Study: Dabrafenib in metastatic melanoma: a monocentric ‘real life’ experience

E Cocorocchio, S Gandini, S Alfieri, A Battaglia, E Pennacchioli, G Tosti, G Spadola, M Barberis, M Di Leo, C Riviello, L Pala, A Intelisano, C Martinoli, PF Ferrucci

3 Mar 2016

https://doi.org/10.3332/ecancer.2016.624

Abstract | Full Article | PDF